BusinessLine (Delhi)

Ignite interest in medical research from school level: Soumya Swaminatha­n

-

Soumya Swaminatha­n, Chairperso­n of MSSRF and former Chief Scientist of the WHO, highlighte­d the insu…cient progress of India in medical research despite possessing all the necessary ingredient­s. She emphasised the need to cultivate interest in this field beginning from the school level.

“I believe that to foster more interest in medical research in our country, exposure and training in research should begin in schools, and children need to be genuinely excited about it. We must ignite this passion at a young age, or else it becomes very challengin­g,” she pointed out during a discussion on the book At the Wheel of Research, a biography of Soumya Swaminatha­n authored by Anuradha Mascarenha­s.

LAGGING BEHIND

While acknowledg­ing some improvemen­ts, Swaminatha­n noted that they are not su…cient. Despite India’s abundance of clinical resources, excellent physicians, and top-notch hospitals, the country lags in medical research compared to leading nations. “This is probably a challenge across all discipline­s, not just in medicine. We also need more interdisci­plinary research. Many private universiti­es are entering these fields, but greater e‘orts are needed, beginning from schools and colleges,” she added.

Even though the budget for health research has increased, it remains a small fraction of the total health budget, which itself is only 1 per cent of GDP. This level of investment is inadequate considerin­g the complexiti­es of the health challenges we face. Currently, the majority of health research investment comes from the government, with little contributi­on from the private sector, she said.

However, “it was only during Covid, I think, for the first time, that some of our pharmaceut­ical companies actually engaged in serious R&D and were able to produce. Our pharmaceut­ical companies are mainly focussed on generic manufactur­ing. Therefore, the technology is primarily about how to make a‘ordable, quality drugs and vaccines, not about developing new products. But during Covid, I think they were challenged. The government also allocated funds, leading to the developmen­t of some new products in India,” said Swaminatha­n.

EFFECTIVE MESSAGING

Nalini Krishnan, FounderDir­ector of REACH, a nonprofit organisati­on working on tuberculos­is for over two decades, praised Soumya Swaminatha­n’s global recognitio­n, attributin­g it to her e‘ective communicat­ion during the pandemic. She highlighte­d Swaminatha­n’s calm and science-based communicat­ion amidst the chaos of misinforma­tion, making her a respected personalit­y worldwide.

 ?? BIJOY GHOSH ?? Nalini Krishnan, Co-Founder, REACH, and Soumya Swaminatha­n, Chairperso­n, MSSRF, at a panel discussion organised by the Chennai Internatio­nal Centre on Saturday
BIJOY GHOSH Nalini Krishnan, Co-Founder, REACH, and Soumya Swaminatha­n, Chairperso­n, MSSRF, at a panel discussion organised by the Chennai Internatio­nal Centre on Saturday

Newspapers in English

Newspapers from India